Health Products

Dimension Clinical Chemistry System and Xpand System - LIPASE Flex (LIPL) Assay, and Dimension EXL SYSTEM - LIPASE (LIPL) Assay (2017-12-17)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
FB8109
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
B. Dimension Xpand System - LIPASE Flex (LIPL) AssayDF56
FB8109
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
C. Dimension EXL SYSTEM - LIPASE (LIPL) AssayDF56
FB8109
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
A. Dimension Clinical Chemistry System - LIPASE Flex (LIPL) AssayDF56

Introduction

Affected products
  1. Dimension Clinical Chemistry System - LIPASE Flex (LIPL) Assay
  2. Dimension Xpand System - LIPASE Flex (LIPL) Assay
  3. Dimension EXL SYSTEM - LIPASE (LIPL) Assay

Reason

Siemens Healthcare Diagnostics has received customer complaints regarding a positive bias in QC results and patient samples when using Dimension Lipase (LIPL) lot FB8109. Siemens internal investigation has confirmed the positive bias with LIPL lot FB8109 when compared to other Dimension LIPL lots. Lot FB8109 is not meeting Siemens internal specifications for lot-to-lot limits. The investigation compared Lot FB8109 with control Lot GB8141 (historical performance representative dimension lipase lot). The lot comparison between dimension LIPL Lot FB8109 and Lot GB8141, when using patient samples, demonstrated an average positive bias of 15%. The range of positive bias of 11% (1028 u/l using Lot GB8141, as reference lot vs 1141 u/l using Lot FB8109) to 22% (94 u/l using Lot GB8141as reference lot vs 114 u/l using Lot FB8109).
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime